Overview

Enbrel Liquid Immunogenicity Protocol

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the antibody formation to Enbrel liquid in subjects with Rheumatoid Arthritis
Phase:
Phase 3
Details
Lead Sponsor:
Amgen
Collaborator:
Immunex Corporation
Treatments:
Etanercept